DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1): recombinant human glycan-binding receptors as analytical tools

European Journal of Cell Biology

Volumn 89, Issue 1, 2010, Pages 87-94

  Samsen, Alexandra ^a   Bogoevska, Valentina ^a   Klampe, Birgit ^a   Bamberger, Ana Maria ^a   Lucka, Lothar ^b   Horst, Andrea K ^a   Nollau, Peter ^a   Wagener, Christoph ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

CEA; CEACAM1; DC SIGN; High mannose glycans; Lectin; Lewisx; SRCL

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD209 ANTIGEN; LECTIN RECEPTOR; PROTEIN SRCL; RECOMBINANT GLYCAN BINDING RECEPTOR; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MASS SPECTROMETRY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANTIGENS, CD; ANTIGENS, CD15; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CELL LINE; COLLECTINS; COLORECTAL NEOPLASMS; FEMALE; FUCOSE; FUCOSYLTRANSFERASES; HUMANS; INTESTINAL MUCOSA; LECTINS, C-TYPE; MELANOMA; PLACENTA; POLYSACCHARIDES; PREGNANCY; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; RECOMBINANT PROTEINS; SKIN NEOPLASMS; TISSUE EXTRACTS;

EID: 73649118456     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2009.11.018     Document Type: Article

References (41)

1. Aarnoudse C.A., Garcia Vallejo J.J., Saeland E., and van Kooyk Y. Recognition of tumor glycans by antigen-presenting cells. Curr. Opin. Immunol. 18 (2006) 105-111
2. Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7 (2007) 139-147
3. Bamberger A.M., Sudahl S., Loning T., Wagener C., Bamberger C.M., Drakakis P., Coutifaris C., and Makrigiannakis A. The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am. J. Pathol. 156 (2000) 1165-1170
4. Barre A., Bourne Y., Van Damme E.J., Peumans W.J., and Rouge P. Mannose-binding plant lectins: different structural scaffolds for a common sugar-recognition process. Biochimie 83 (2001) 645-651
5. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., Bryan M.C., Fazio F., Calarese D., Stevens J., Razi N., Stevens D.J., Skehel J.J., van Die I., Burton D.R., Wilson I.A., Cummings R., Bovin N., Wong C.H., and Paulson J.C. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101 (2004) 17033-17038
6. Bockle B.C., Solder E., Kind S., Romani N., and Sepp N.T. DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 29 (2008) 187-192
7. Bogoevska V., Horst A., Klampe B., Lucka L., Wagener C., and Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues. Glycobiology 16 (2006) 197-209
8. Bogoevska V., Nollau P., Lucka L., Grunow D., Klampe B., Uotila L.M., Samsen A., Gahmberg C.G., and Wagener C. DC-SIGN binds ICAM-3 isolated from peripheral human leukocytes through Lewis x residues. Glycobiology 17 (2007) 324-333
9. x trisaccharide and related glycan ligands. J. Biol. Chem. 280 (2005) 22993-22999
10. de Vries T., Knegtel R.M., Holmes E.H., and Macher B.A. Fucosyltransferases: structure/function studies. Glycobiology 11 (2001) 119R-128R
11. Ebrahimnejad A., Streichert T., Nollau P., Horst A.K., Wagener C., Bamberger A.M., and Brummer J. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am. J. Pathol. 165 (2004) 1781-1787
12. Fox N., Damjanov I., Knowles B.B., and Solter D. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res. 43 (1983) 669-678
13. Geijtenbeek T.B., Krooshoop D.J., Bleijs D.A., van Vliet S.J., van Duijnhoven G.C., Grabovsky V., Alon R., Figdor C.G., and van Kooyk Y. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1 (2000) 353-357
14. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
15. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., and Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
16. Gooi H.C., Feizi T., Kapadia A., Knowles B.B., Solter D., and Evans M.J. Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature 292 (1981) 156-158
17. Guo Y., Feinberg H., Conroy E., Mitchell D.A., Alvarez R., Blixt O., Taylor M.E., Weis W.I., and Drickamer K. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11 (2004) 591-598
18. Hinoda Y., Neumaier M., Hefta S.A., Drzeniek Z., Wagener C., Shively L., Hefta L.J., Shively J.E., and Paxton R.J. Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 85 (1988) 6959-6963
19. Horst A.K., and Wagener C. CEA-related CAMs. In: Behrens J., and Nelson W.J. (Eds). Handbook of Pharmacology (2004), Springer, Berlin-Heidelberg 283-341
20. Horst A.K., and Wagener C. CEACAM1 adhesion molecule. In: Schwab M. (Ed). Encyclopedia of Cancer (2009), Springer, Berlin-Heidelberg 562-566
21. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., Hong S.M., Fu B., Lin M.T., Calhoun E.S., Kamiyama M., Walter K., Nikolskaya T., Nikolsky Y., Hartigan J., Smith D.R., Hidalgo M., Leach S.D., Klein A.P., Jaffee E.M., Goggins M., Maitra A., Iacobuzio-Donahue C., Eshleman J.R., Kern S.E., Hruban R.H., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B., Velculescu V.E., and Kinzler K.W. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 (2008) 1801-1806
22. Leusch H.G., Hefta S.A., Drzeniek Z., Hummel K., Markos-Pusztai Z., and Wagener C. Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett. 261 (1990) 405-409
23. Leusch H.G., Drzeniek Z., Markos-Pusztai Z., and Wagener C. Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose. Infect. Immun. 59 (1991) 2051-2057
24. Lucka L., Fernando M., Grunow D., Kannicht C., Horst A.K., Nollau P., and Wagener C. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology 15 (2005) 87-100
25. Markel G., Lieberman N., Katz G., Arnon T.I., Lotem M., Drize O., Blumberg R.S., Bar-Haim E., Mader R., Eisenbach L., and Mandelboim O. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 168 (2002) 2803-2810
26. Neumaier M., Paululat S., Chan A., Matthaes P., and Wagener C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA 90 (1993) 10744-10748
27. Nishihara S., Iwasaki H., Kaneko M., Tawada A., Ito M., and Narimatsu H. Alpha 1,3-fucosyltransferase 9 (FUT9; Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four alpha 1,3 FUT members preferentially fucosylate the inner GlcNAc residue. FEBS Lett. 462 (1999) 289-294
28. Obrink B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr. Opin. Cell Biol. 9 (1997) 616-626
29. Obrink B., Ocklind C., and Rubin K. Cell surface molecules involved in hepatocyte intercellular adhesion. Prog. Clin. Biol. Res. 102 Part A (1982) 491-498
30. Ocklind C., and Obrink B. Intercellular adhesion of rat hepatocytes. Identification of a cell surface glycoprotein involved in the initial adhesion process. J. Biol. Chem. 257 (1982) 6788-6795
31. Oikawa S., Kosaki G., and Nakazato H. Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA). Biochem. Biophys. Res. Commun. 146 (1987) 464-469
32. Prall F., Nollau P., Neumaier M., Haubeck H.-D., Drzeniek Z., Helmchen U., Löning T., and Wagener C. CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium and myeloid cells in a wide range of normal human tissues. J. Histochem. Cytochem. 44 (1995) 35-41
33. Selman L., Skjodt K., Nielsen O., Floridon C., Holmskov U., and Hansen S. Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues. Mol. Immunol. 45 (2008) 3278-3288
34. Stoffel A., Neumaier M., Gaida F.-J., Fenger U., Drzeniek Z., Haubeck H.-D., and Wagener C. Monoclonal, anti-domain and anti-peptides antibodies assign the Mr 160,000 antigen of the CD66 cluster to a mRNA encoded by the biliary glycoprotein (BGP) gene, a member of the carcinoembryonic antigen (CEA) gene family. J. Immunol. 150 (1993) 4978-4984
35. Streit A., Yuen C.T., Loveless R.W., Lawson A.M., Finne J., Schmitz B., Feizi T., and Stern C.D. The Le(x) carbohydrate sequence is recognized by antibody to L5, a functional antigen in early neural development. J. Neurochem. 66 (1996) 834-844
36. Taylor M.E., and Drickamer K. Paradigms for glycan-binding receptors in cell adhesion. Curr. Opin. Cell Biol. 19 (2007) 572-577
37. Thies A., Moll I., Berger J., Wagener C., Brummer J., Schulze H.J., Brunner G., and Schumacher U. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol. 20 (2002) 2530-2536
38. Thom I., Schult-Kronefeld O., Burkholder I., Schuch G., Andritzky B., Kastendieck H., Edler L., Wagener C., Bokemeyer C., Schumacher U., and Laack E. Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. Anticancer Res. 29 (2009) 249-254
39. van Gisbergen K.P., Aarnoudse C.A., Meijer G.A., Geijtenbeek T.B., and van Kooyk Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 65 (2005) 5935-5944
40. van Gisbergen K.P., Ludwig I.S., Geijtenbeek T.B., and van Kooyk Y. Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils. FEBS Lett. 579 (2005) 6159-6168
41. Zelensky A.N., and Gready J.E. The C-type lectin-like domain superfamily. FEBS J. 272 (2005) 6179-6217